Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Prospective characterization of oral and gut microbiome in a high-risk pancreatic cancer cohort.
Authors
Seyda Baydogan
Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, TX;
Seyda Baydogan , Chirayu Mohindroo , Maria Fernanda Montiel , Joseph Petrosino , Anirban Maitra , Michael Paul Kim , Manoop S. Bhutani , James R White , Florencia McAllister
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 691)
DOI
10.1200/JCO.2023.41.4_suppl.691
Abstract #
691
Poster Bd #
J16
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
PSMA-based PET as an imaging biomarker of androgen receptor signaling in high-risk localized and locally advanced prostate cancer (PCa).
First Author: Keara English
Poster
2023 ASCO Quality Care Symposium
Analysing the colorectal cancer screening patterns during the COVID-19 pandemic and their effects on patient outcomes.
First Author: Joshua Ling
Poster
2023 ASCO Annual Meeting
The impact of extending CRC screening to the older population: Results from CRC-AIM microsimulation model.
First Author: Derek W. Ebner
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Pancreatic imaging findings from the PRECEDE study: A large high-risk heritable cohort for pancreatic cancer.
First Author: Ido Haimi